48 results about "Lactose Powder" patented technology

The method for increasing lactose tolerance in subjects exhibiting lactose intolerance symptoms implements a protocol where the subjects ingest a gradually increasing amount of lactose containing product over a six week period. At various points during the six week period the subject ingests the lactose containing product once a day and then twice a day. The lactose containing product can be in liquid form, such as for example, milk, and is preferably in a powder form which is taken either by ingesting capsules having the lactose powder or in a granular form mixed with water or other non-lactose containing liquid. At the end of the six week period, the subject's tolerance for lactose containing products is substantially increased, with the potential of eliminating the subject's lactose intolerant behavior indefinitely.

The present invention relates to an infant formula milk powder capable of preventing and alleviating infant iron deficiency anemia and a preparation method thereof. The formula milk powder comprises components such as vegetable oil, fresh milk, whey powder, lactose powder, whey protein powder, oligosaccharides, complex vitamins and complex minerals, wherein the lactoferrin and vitamin C, or alternatively, an iron source (calculated as iron), lactoferrin and vitamin C are maintained in the appropriate mass ratios, and the formula milk powder of the present invention is obtained by performing mixing, homogenizing, cooling, concentrating and spray-drying, packaging or directly using a step-by-step mixing method. The formula milk powder comprises appropriate amounts of vitamin C and lactoferrin, as well as an appropriate amount of iron source as further provided, and the three are combined according to an appropriate proportion, so that the combination of the three kinds of the substances have a synergistic effect, and the absorption and utilization rate of iron are increased dramatically, thereby not only achieving the desirable iron supplementation effect, but also preventing and alleviating the phenomenon of infant iron deficiency anemia.

The invention discloses a preparation method of Saccharomyces cerevisiae and isomerized lactose powder, which comprises the following steps: adding Saccharomyces cerevisiae LJSM‑01 to a lactose isomerization solution, carrying out fermentation, and removing galactose in the solution; removing galactose The fermented lactose liquid is subjected to sterilizing, decolorizing, ion exchange and evaporative concentration, followed by simulated moving bed chromatographic purification, and the obtained isomerized lactose solution is concentrated and crystallized to obtain isomerized lactose powder. The Saccharomyces cerevisiae can ferment all the galactose in it without fermenting the isomerized lactose. It adopts the two-step purification method of fermentation method and simulated moving bed chromatography separation method, and the obtained isomerized lactose liquid has high purity, The advantage of high yield meets the requirements of industrial production.

The invention discloses a milk tea tablet. The milk tea tablet is prepared from raw material in parts by weight: 10-14 parts of whole milk powder, 0.4-1.5 parts of black tea powder, 3-8 parts of sucrose powder, 3-15 parts of lactose powder, 0.2-0.5 part of sodium carboxymethyl cellulose, 0.0001-0.03 part of ethyl maltol, and 1-4 parts of corn starch. The invention also discloses a process for producing the milk tea tablet. The instant milk tea tablet has rich milk tea flavor, mellow mouth feeling, and moderate saccharinity; and the milk tea tablet prepared by the prescription is difficult to disintegrate, has stable structure, can be directly eaten or brewed to drink, and is an ideal leisure food. Meanwhile, the consumer can add coffee powder or chocolate powder and the like into the milktea according to personal taste to form corresponding flavor milk tea.

theThe invention discloses a Manidipine dihydrochloride tablet for treating hypertension and a preparation method thereof. The tablet contains Manidipine dihydrochloride, sodium dodecanesulphonate, polyethylene glycol 6000, lactose and magnesium stearate. The preparation method comprises the following steps: (1) fusion of polyethylene glycol 6000 is carried out; (2) Manidipine dihydrochloride, sodium dodecanesulphonate and lactose are crushed, and then the materials and fused polyethylene glycol 6000 mixed by a powder injection apparatus; (3) the materials mixed in the step (2) are heated to 120-150 DEG C, stirring is carried out at a rotating speed of 220-280 r / min for 1-2 minutes, cooling is carried out for 75-85 DEG C, magnesium stearate is added and stirring is carried out for 30 minutes, materials are transferred to a drying box, drying is carried out, and materials are dried and pressed into tablets in order to obtain the Manidipine dihydrochloride tablet. The invention providesthe Manidipine dihydrochloride tablet for treating hypertension, the tablet has higher dissolution rate, the dissolution rate of the tablet reaches 98.2% or above, the preparation method is stable andreliable, and the method is suitable for industrialized production.

Disclosed is the 3D printing of pharmaceutical formulations, such as tablets, wherein a binder liquid is deposited dropwise on a layer of powder, with these steps being repeated, in one or more patterns, in order to generate a solid drug product. In accordance with the invention, the powder comprises lactose particles having a particle size distribution characterized by a D10 of at least 6 micrometers.